Ketoconazole in the prevention of experimental candidal vaginitis.
AUTOR(ES)
Sobel, J D
RESUMO
The prophylactic and therapeutic activities of ketoconazole were evaluated in rats inoculated intravaginally with Candida albicans. Daily doses of 2.5 mg/kg initiated 48 h before challenge and continued for 48 h thereafter protected 80% of the rats against infection. A similar result in rats with established infection was attained with daily doses of 5.0 mg/kg.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=185491Documentos Relacionados
- Comparison of itraconazole and ketoconazole in the treatment of experimental candidal vaginitis.
- Modulation of cell surface-associated mannoprotein antigen expression in experimental candidal vaginitis.
- Critical role of germ tube formation in the pathogenesis of candidal vaginitis.
- Efficacy of D0870 treatment of experimental Candida vaginitis.
- Persistent vaginitis.
